Literature DB >> 20178716

NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis.

H Z Al-Shahrouri1, P Ramirez, P Fanti, H Abboud, C Lorenzo, S Haffner.   

Abstract

UNLABELLED: Lipoprotein abnormalities are likely contributors to the high risk of cardiovascular disease in the chronic kidney disease (CKD) population, although information is limited. Specifically, little is known about lipoprotein abnormalities during the early stages of diabetic kidney disease. The aim of this study was to investigate the relationship between lipoproteins and early manifestations of CKD in the 517 Type 2 diabetes mellitus (T2DM) patients who participated in the Insulin Resistance Atherosclerosis Study (IRAS).
METHODS: Lipoprotein abnormalities were measured by conventional lipid analysis, nuclear magnetic resonance (NMR) spectroscopy, gel gradient electrophoresis (GE), immunoprecipitation (IP), and ELISA. We grouped the cases into albumin to creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR) quartiles.
RESULTS: In the conventional lipid analysis, triglycerides (TG) correlated directly with ACR and inversely with eGFR quartiles (p = 0.01), while LDL, HDL cholesterol did not correlate with change in ACR or eGFR. ACR was directly associated with apoB, total VLDL, medium VLDL, IDL and small LDL particle concentrations (p < or = 0.03), and inversely with large LDL particles (p = 0.01) and LDL size (p = 0.008). Estimated GFR quartiles were inversely associated with total VLDL, small VLDL, IDL, and medium HDL particles (p < or = 0.01).
CONCLUSION: In subjects with T2DM, mild albuminuria and reduction in eGFR were associated with numerous atherogenic lipoprotein abnormalities that were detected by the combination of NMR spectroscopy, gel gradient electrophoresis, immunoprecipitation and ELISA but not by the standard clinical lipid analysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178716     DOI: 10.5414/cnp73180

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

1.  Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.

Authors:  Arpita Basu; Alicia J Jenkins; Ying Zhang; Julie A Stoner; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; Timothy J Lyons
Journal:  Atherosclerosis       Date:  2015-10-31       Impact factor: 5.162

2.  Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study.

Authors:  Mahboob Rahman; Wei Yang; Sanjeev Akkina; Arnold Alper; Amanda Hyre Anderson; Lawrence J Appel; Jiang He; Dominic S Raj; Jeffrey Schelling; Louise Strauss; Valerie Teal; Daniel J Rader
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 8.237

Review 3.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

4.  High-density lipoprotein particle pattern and overall lipid responses to a short-term moderate-intensity aerobic exercise training intervention in patients with chronic kidney disease.

Authors:  Emily M Miele; Samuel A E Headley; Michael Germain; Jyovani Joubert; Sarah Herrick; Charles Milch; Elizabeth Evans; Allen Cornelius; Britton Brewer; Beth Taylor; Richard J Wood
Journal:  Clin Kidney J       Date:  2017-03-27

Review 5.  Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.

Authors:  Lucas Opazo-Ríos; Sebastián Mas; Gema Marín-Royo; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

6.  Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients.

Authors:  Marcelino Bermudez-Lopez; Hector Perpiñan; Nuria Amigo; Eva Castro; Nuria Alonso; Didac Mauricio; Elvira Fernandez; Jose M Valdivielso
Journal:  Clin Kidney J       Date:  2021-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.